产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 98% | 询价 | |||
| 5mg | 98% | 询价 | |||
| 10mg | 98% | 询价 | |||
| 25mg | 98% | 询价 | |||
| 50mg | 98% | 询价 | |||
| 100mg | 98% | 询价 | |||
| 250mg | 98% | 询价 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 98% | 询价 | |||
| 5mg | 98% | 询价 | |||
| 10mg | 98% | 询价 | |||
| 25mg | 98% | 询价 | |||
| 50mg | 98% | 询价 | |||
| 100mg | 98% | 询价 | |||
| 250mg | 98% | 询价 |
CAS No. |
1204918-72-8 |
|---|---|
中文名称 |
(8E)-6-甲基-21,22-二氢-12-氧杂-3,6-二氮杂-2(6,2)-嘧啶-1,4(1,3)-二苯环十二蕃-8-烯 |
英文名称 |
(8E)-6-Methyl-21,22-dihydro-12-oxa-3,6-diaza-2(6,2)-pyrimidina-1,4(1,3)-dibenzenacyclododecaphan-8-ene |
别名 |
SB1317;TG02;SB1317 (Double bond E);TG02 (Double bond E);SB1317 (TG-02);VXBAJLGYBMTJCY-UHFFFAOYSA-N;CS-1850;20-Oxa-5,7,14,27-tetraazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2,4,6(27),8,10,12(26),16,21,23-decaene, 14-methyl-, (16E)- |
标准英文名 |
(22E,8E)-6-methyl-21,22-dihydro-12-oxa-3,6-diaza-2(6,2)-pyrimidina-1,4(1,3)-dibenzenacyclododecaphan-8-ene |
分子式 |
C23H24N4O |
分子量 |
372.47 |
精确分子量 |
372.20 |
SMILES |
CN(CC1=CC(/N=C2NC3=CC=N\2)=CC=C1)C/C=C/CCOC4=CC3=CC=C4 |
标准SMILES |
CN1CC2C=CC=C(C=2)N=C2NC(=CC=N2)C2C=C(C=CC=2)OCCC=CC1 |
性状 |
White to yellow powder or crystals |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Warning |
InChIKey |
VXBAJLGYBMTJCY-NSCUHMNNSA-N |
危险类别(旧) |
H302 |
存储要求 |
Sealed in dry, 2-8°C,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral,Skin corrosion/irritation (Category 2),Serious eye damage/eye irritation (Category 2A),Specific target organ toxicity, single exposure; Respiratory system (Category 3) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|